AMINO LEVULINIC ACID 5 - ALA - 24 HRS URINE

Amino Levulinic Acid 5-ALA - 24 Hrs Urine is a specialized laboratory test used to measure the amount of 5-aminolevulinic acid, also known as delta-aminolevulinic acid or ALA, excreted in urine over a complete 24-hour period. ALA is an intermediate substance produced during the body's formation of heme, an essential component of hemoglobin and several important enzymes.

Abnormal accumulation and increased urinary excretion of ALA may occur when the heme-production pathway is disrupted. This can be associated with acute hepatic porphyrias, aminolevulinic acid dehydratase deficiency porphyria, lead exposure, or other conditions affecting heme synthesis. The test supports diagnosis but must be interpreted with porphobilinogen, porphyrin studies, blood lead measurements, symptoms, medicines, and clinical history.

Benefits of the Test

• Measures total urinary ALA excretion over 24 hours.
• Supports evaluation of suspected acute porphyria.
• Helps assess abnormalities in the heme-synthesis pathway.
• May support investigation of possible lead exposure.
• Assists in evaluating recurrent unexplained abdominal or neurological symptoms.
• Helps guide additional porphyrin and porphobilinogen testing.
• May support monitoring in selected diagnosed patients.
• Provides reliable laboratory-based biochemical assessment.

Why Doctors Recommend This Test

Doctors may recommend this test for individuals experiencing severe recurrent abdominal pain, nausea, vomiting, constipation, muscle weakness, limb pain, confusion, seizures, behavioral changes, dark or reddish urine, or other symptoms suggestive of an acute porphyria. It may also be requested when occupational, environmental, or accidental lead exposure is suspected. Blood lead measurement remains the preferred test for confirming lead exposure, particularly in children.

Preparation Before Test

• A complete 24-hour urine collection is required.
• Avoid alcohol for at least 24 hours before and throughout the collection period.
• Inform the doctor about all medicines, supplements, and recent treatments.
• Do not stop prescribed medicines unless instructed by the treating doctor.
• Use only the laboratory-provided collection container and preservative, if supplied.
• Protect the collection container from direct light throughout the collection period.
• Keep the container refrigerated or as instructed by the laboratory.
• Record the collection start time, completion time, and total urine volume.
• Follow all 24-hour urine collection and transportation instructions carefully.

Normal Reporting Time

Most Amino Levulinic Acid 5-ALA - 24 Hrs Urine reports at Focus Diagnostics are initiated within 2–3 hours of sample receipt for processing and specialized biochemical testing workflow preparation. Final ALA measurement, calculation of 24-hour excretion, quality review, validation, and reporting are generally completed within several working days, depending on laboratory protocols and quality-assurance requirements.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected acute hepatic porphyria.
• Patients with severe recurrent unexplained abdominal pain.
• People with neurological or psychiatric symptoms associated with abdominal attacks.
• Individuals with dark or reddish urine during symptomatic episodes.
• Workers with possible occupational lead exposure.
• People with suspected environmental or accidental lead exposure.
• Patients with abnormal porphobilinogen or porphyrin results.
• Individuals undergoing specialist evaluation of a heme-synthesis disorder.

Detailed Information

Heme is an essential molecule used in hemoglobin, myoglobin, cytochromes, and several enzymes. The body produces heme through a sequence of biochemical reactions. 5-Aminolevulinic acid is formed during an early stage of this pathway and is normally converted into porphobilinogen by the enzyme ALA dehydratase.

If an enzyme within the heme-synthesis pathway is deficient or inhibited, ALA may accumulate in the body and be excreted in increased quantities through urine. Measuring urinary ALA can therefore provide useful information about disorders affecting porphyrin and heme metabolism.

Acute hepatic porphyrias are inherited metabolic disorders involving enzymes required for heme production. During an acute attack, patients may experience severe abdominal pain, vomiting, constipation, rapid heart rate, high blood pressure, muscle weakness, limb or back pain, anxiety, confusion, seizures, or reduced consciousness.

Symptoms of acute porphyria are not specific and may resemble many gastrointestinal, neurological, psychiatric, or medical conditions. ALA measurement should therefore be interpreted with urine porphobilinogen, urine porphyrins, plasma or fecal porphyrin studies, enzyme testing, and molecular genetic analysis when indicated.

Lead inhibits enzymes involved in heme production, including ALA dehydratase. This can result in increased ALA formation and urinary excretion. However, urinary ALA is not the preferred standalone test for confirming lead poisoning. Venous blood lead measurement is generally required to assess current exposure and guide treatment.

A 24-hour urine collection measures all urine produced during an entire day and provides an estimate of total daily ALA excretion. Missing a urine sample, collecting beyond or below the required period, or failing to record the total volume can produce an inaccurate result.

To begin collection, the first urine passed at the selected start time is usually discarded, and the time is recorded. Every subsequent urine sample is collected for the next 24 hours, including the final sample passed at the exact completion time. The laboratory's specific instructions must always be followed.

ALA and related porphyrin compounds may be affected by light, temperature, urine pH, and improper storage. The collection container should therefore be protected from light and kept refrigerated or preserved according to laboratory instructions. The laboratory should provide the correct container and advise whether a preservative is required.

Alcohol and certain medicines can affect heme synthesis or porphyrin-related test results. A complete list of medicines, supplements, recent treatments, alcohol use, occupational exposure, and symptoms should be provided to the doctor and laboratory.

An elevated result does not independently identify the exact cause. Further testing may include urine porphobilinogen, quantitative urine porphyrins, plasma porphyrins, fecal porphyrin analysis, blood lead testing, complete blood count, liver-function tests, enzyme assays, or genetic testing.

When acute porphyria is suspected, collection during a symptomatic episode may provide the most useful biochemical information. Severe abdominal pain accompanied by weakness, confusion, seizures, breathing difficulty, or reduced consciousness requires urgent medical evaluation.

At Focus Diagnostics, Amino Levulinic Acid 5-ALA - 24 Hrs Urine testing is performed using advanced biochemical analytical technologies, validated testing methodologies, light-protected sample-processing procedures, and stringent quality-assurance standards to provide accurate, reliable, and clinically meaningful results.